These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33180327)

  • 1. Cutaneous eruption in COVID-19-infected patients in Thailand: An observational descriptive study.
    Punyaratabandhu P; Chirachanakul P
    J Dermatol; 2021 Jan; 48(1):14-20. PubMed ID: 33180327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favipiravir-induced cutaneous adverse reactions in patients infected with COVID-19.
    Punyaratabandhu P; Vanitchpongphan S
    Clin Exp Dermatol; 2022 Mar; 47(3):573-577. PubMed ID: 34592006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
    Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review on treatment-related mucocutaneous reactions in COVID-19 patients.
    Najar Nobari N; Seirafianpour F; Mashayekhi F; Goodarzi A
    Dermatol Ther; 2021 Jan; 34(1):e14662. PubMed ID: 33301232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety assessment of drug combinations used in COVID-19 treatment: in silico toxicogenomic data-mining approach.
    Baralić K; Jorgovanović D; Živančević K; Antonijević Miljaković E; Antonijević B; Buha Djordjevic A; Ćurčić M; Đukić-Ćosić D
    Toxicol Appl Pharmacol; 2020 Nov; 406():115237. PubMed ID: 32920000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.
    Zekarias A; Watson S; Vidlin SH; Grundmark B
    Drug Saf; 2020 Dec; 43(12):1309-1314. PubMed ID: 32978702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination.
    Lim PN; Wylie G
    Clin Exp Dermatol; 2022 Jan; 47(1):175-176. PubMed ID: 34399001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital.
    Fernandez-Nieto D; Ortega-Quijano D; Jimenez-Cauhe J; Burgos-Blasco P; de Perosanz-Lobo D; Suarez-Valle A; Cortes-Cuevas JL; Carretero I; Garcia-Del Real C; Fernandez-Guarino M
    Clin Exp Dermatol; 2020 Oct; 45(7):872-875. PubMed ID: 32384180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin manifestations associated with the new coronavirus SARS-CoV-2 disease.
    Redondo-Sendino Á; González Sánchez IC; de Victoria Fernández B
    Med Clin (Barc); 2020 Nov; 155(9):414-415. PubMed ID: 32873395
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe urticarial rash as the initial symptom of COVID-19 infection.
    Pagali S; Parikh RS
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33766974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Hassaniazad M; Bazram A; Hassanipour S; Fathalipour M
    Trials; 2020 Oct; 21(1):886. PubMed ID: 33109246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous manifestations of Coronavirus Disease 2019.
    Ghafoor R; Ali SM; Goldust M
    J Cosmet Dermatol; 2022 Sep; 21(9):3667-3672. PubMed ID: 35866336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleomorphicskin eruptions in a COVID-19 affected patient: Case report and review of the literature.
    Scala E; Fania L; Bernardini F; Calarco R; Chiloiro S; Di Campli C; Erculei S; Giani M; Giordano M; Panebianco A; Passarelli F; Trovè A; Verkhovskaia S; Russo G; Sgadari A; Didona B; Abeni D
    Immun Inflamm Dis; 2021 Sep; 9(3):617-621. PubMed ID: 33942541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study.
    Liu X; Chen H; Shang Y; Zhu H; Chen G; Chen Y; Liu S; Zhou Y; Huang M; Hong Z; Xia J
    Trials; 2020 Jul; 21(1):622. PubMed ID: 32641091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both Chloroquine and Lopinavir/Ritonavir Are Ineffective for COVID-19 Treatment and Combined Worsen the Pathology: A Single-Center Experience with Severely Ill Patients.
    Sevilla-Castillo F; Roque-Reyes OJ; Romero-Lechuga F; Gómez-Núñez MF; Castillo-López M; Medina-Santos D; Román PO; Flores-Hernández JR; Méndez-Coca JD; Montaño-Olmos D; Farfán-Lazos KC; Tobón-Cubillos M; Viveros-Hernández A; Torres-Ortega L; Hernández-Skewes KY; Montiel-Bravo G; Ortega-Rodríguez S; Peón AN
    Biomed Res Int; 2021; 2021():8821318. PubMed ID: 33732744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute generalized exanthematous pustulosis induced by HIV postexposure prophylaxis with lopinavir-ritonavir.
    Ghosn J; Duvivier C; Tubiana R; Katlama C; Caumes E
    Clin Infect Dis; 2005 Nov; 41(9):1360-1. PubMed ID: 16206117
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous signs in COVID-19 patients: A review.
    Wollina U; Karadağ AS; Rowland-Payne C; Chiriac A; Lotti T
    Dermatol Ther; 2020 Sep; 33(5):e13549. PubMed ID: 32390279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel.
    Zequn Z; Yujia W; Dingding Q; Jiangfang L
    Eur J Pharmacol; 2021 Feb; 893():173813. PubMed ID: 33345848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute generalized exanthematous pustulosis due to fluconazole].
    Fabre B; Albès B; Belhadjali H; Bazex J
    Ann Dermatol Venereol; 2002 Mar; 129(3):294-7. PubMed ID: 11988684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.
    Young BE; Ong SWX; Kalimuddin S; Low JG; Tan SY; Loh J; Ng OT; Marimuthu K; Ang LW; Mak TM; Lau SK; Anderson DE; Chan KS; Tan TY; Ng TY; Cui L; Said Z; Kurupatham L; Chen MI; Chan M; Vasoo S; Wang LF; Tan BH; Lin RTP; Lee VJM; Leo YS; Lye DC;
    JAMA; 2020 Apr; 323(15):1488-1494. PubMed ID: 32125362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.